Changes in Body Weight in Severely Obese Patients Treated with the Anorexiant Mazindol
(1) <b>Background</b>: The number of severely obese patients worldwide is rapidly increasing. Recently, novel therapeutic approaches, such as bariatric surgery or GLP-1 receptor agonists, have emerged, bringing about a paradigm shift in this field. However, these therapies sometimes face...
Main Authors: | Yoshimitsu Tanaka, Norikazu Maeda, Masahiro Koseki, Kazuhisa Maeda |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/13/7/1860 |
Similar Items
-
Combined First Month Body Weight Loss and Development of Tolerance as Predictors of 6-Month Efficacy of Mazindol in Mild and Moderate Obese Subjects
by: Juan Carlos Huerta-Cruz, et al.
Published: (2022-06-01) -
Anorexie
by: Clarisse Ruffieux, et al.
Published: (2023-09-01) -
L'anorexie mentale
by: Aricia Andrey, et al.
Published: (2023-09-01) -
Compter pour “rien”: l’objet dans la clinique de l’anorexie
by: Lyasmine Kessaci
Published: (2023-10-01) -
Perdre l’appétit. Le refus de l’autre comme quête de soi. Exemples sahariens, japonais et français
by: Cristina Figueiredo
Published: (2023-04-01)